CD209 and HIV-1 infection: We previously demonstrated that fusion protein CLDs consisting of the D1D2 domain of CD4 and the neck domain (ND) and carbohydrate-recognition domain (CRD) of DC-SIGN produced in E. coli could efficiently inhibit HIV-1 infection in vitro and ex vivo.